key,start_date,end_date,edinet_key,period,value,announce_date
net_sales,2014-01-01,2014-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration,78172000,201505141710
net_sales,2015-01-01,2015-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration,67551000,201505141710
net_sales,2014-01-01,2014-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration,277759000,201505141710
ordinary_income,2014-01-01,2014-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration,-285391000,201505141710
ordinary_income,2015-01-01,2015-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration,-350052000,201505141710
ordinary_income,2014-01-01,2014-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration,-883352000,201505141710
net_income,2014-01-01,2014-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration,-267989000,201505141710
net_income,2015-01-01,2015-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration,-349299000,201505141710
net_income,2014-01-01,2014-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration,-863269000,201505141710
comprehensive_income,2014-01-01,2014-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration,-267989000,201505141710
comprehensive_income,2015-01-01,2015-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration,-349299000,201505141710
comprehensive_income,2014-01-01,2014-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration,-863269000,201505141710
net_asset,2014-10-01,2014-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant,4407813000,201505141710
net_asset,2015-01-01,2015-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant,5489119000,201505141710
net_asset,2014-01-01,2014-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant,5839466000,201505141710
total_asset,2014-10-01,2014-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant,4806967000,201505141710
total_asset,2015-01-01,2015-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant,5880622000,201505141710
total_asset,2014-01-01,2014-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant,6257267000,201505141710
eps,2014-01-01,2014-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration,-13.27,201505141710
eps,2015-01-01,2015-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration,-15.92,201505141710
eps,2014-01-01,2014-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration,-42.36,201505141710
diluted_eps,2014-01-01,2014-03-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior1YTDDuration,－,201505141710
diluted_eps,2015-01-01,2015-03-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,CurrentYTDDuration,－,201505141710
diluted_eps,2014-01-01,2014-03-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior1YearDuration,－,201505141710
equity_ratio,2014-10-01,2014-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant,0.911,201505141710
equity_ratio,2015-01-01,2015-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant,0.931,201505141710
equity_ratio,2014-01-01,2014-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant,0.929,201505141710
cost_of_sales,2014-01-01,2014-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration,27684000,201505141710
cost_of_sales,2015-01-01,2015-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration,23964000,201505141710
gross_profit,2014-01-01,2014-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration,50487000,201505141710
gross_profit,2015-01-01,2015-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration,43587000,201505141710
operating_income,2014-01-01,2014-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration,-285318000,201505141710
operating_income,2015-01-01,2015-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration,-351496000,201505141710
operating_income,2014-01-01,2014-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration,-285318000,201505141710
operating_income,2015-01-01,2015-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration,-351496000,201505141710
net_sales,2014-04-01,2014-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration,158058000,201508141506
net_sales,2015-04-01,2015-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration,133917000,201508141506
ordinary_income,2014-04-01,2014-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration,-582379000,201508141506
ordinary_income,2015-04-01,2015-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration,-684952000,201508141506
net_income,2014-04-01,2014-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration,-557533000,201508141506
net_income,2015-04-01,2015-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration,-701288000,201508141506
comprehensive_income,2014-04-01,2014-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration,-557533000,201508141506
comprehensive_income,2015-04-01,2015-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration,-701288000,201508141506
net_asset,2015-01-01,2015-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant,4111778000,201508141506
net_asset,2015-04-01,2015-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant,5160363000,201508141506
total_asset,2015-01-01,2015-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant,4532503000,201508141506
total_asset,2015-04-01,2015-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant,5441534000,201508141506
eps,2014-04-01,2014-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration,-27.55,201508141506
eps,2015-04-01,2015-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration,-31.93,201508141506
eps,2015-01-01,2015-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration,-14.28,201508141506
eps,2015-04-01,2015-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration,-16.02,201508141506
equity_ratio,2015-01-01,2015-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant,0.902,201508141506
equity_ratio,2015-04-01,2015-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant,0.945,201508141506
cost_of_sales,2014-04-01,2014-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration,54609000,201508141506
cost_of_sales,2015-04-01,2015-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration,56077000,201508141506
gross_profit,2014-04-01,2014-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration,103448000,201508141506
gross_profit,2015-04-01,2015-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration,77839000,201508141506
operating_income,2014-04-01,2014-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration,-581867000,201508141506
operating_income,2015-04-01,2015-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration,-722088000,201508141506
operating_income,2014-04-01,2014-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration,-581867000,201508141506
operating_income,2015-04-01,2015-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration,-722088000,201508141506
net_sales,2015-07-01,2015-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,216532000,201511121504
net_sales,2014-07-01,2014-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,186438000,201511121504
ordinary_income,2015-07-01,2015-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-920486000,201511121504
ordinary_income,2014-07-01,2014-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-837843000,201511121504
net_income,2015-07-01,2015-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-949602000,201511121504
net_income,2014-07-01,2014-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-885498000,201511121504
comprehensive_income,2015-07-01,2015-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-949602000,201511121504
comprehensive_income,2014-07-01,2014-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-885498000,201511121504
net_asset,2015-07-01,2015-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4888767000,201511121504
net_asset,2014-07-01,2014-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,5815125000,201511121504
total_asset,2015-07-01,2015-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,5140022000,201511121504
total_asset,2014-07-01,2014-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,6111493000,201511121504
eps,2015-07-01,2015-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-43.18,201511121504
eps,2014-07-01,2014-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-43.45,201511121504
eps,2015-07-01,2015-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-12.37,201511121504
diluted_eps,2015-07-01,2015-09-30,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,－,201511121504
diluted_eps,2014-07-01,2014-09-30,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,－,201511121504
equity_ratio,2015-07-01,2015-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.947,201511121504
equity_ratio,2014-07-01,2014-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.949,201511121504
number_of_shares,2015-07-01,2015-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,22046200,201511121504
number_of_shares,2014-07-01,2014-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,21945800,201511121504
cost_of_sales,2015-07-01,2015-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,98014000,201511121504
gross_profit,2015-07-01,2015-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,118517000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-936845000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAllianceReportableSegmentsMember,94788000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000LeadAntibodyLicensingReportableSegmentsMember,－,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000LicensingOutPlatformTechnologyReportableSegmentsMember,23729000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember,118517000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,118517000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-1055363000,201511121504
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-936845000,201511121504
net_sales,2010-01-01,2010-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior5YearDuration,－,201603291507
net_sales,2011-01-01,2011-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration,－,201603291507
net_sales,2012-01-01,2012-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration,－,201603291507
net_sales,2013-01-01,2013-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration,434962000,201603291507
net_sales,2015-01-01,2015-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration,－,201603291507
ordinary_income,2010-01-01,2010-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior5YearDuration,－,201603291507
ordinary_income,2011-01-01,2011-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration,－,201603291507
ordinary_income,2012-01-01,2012-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration,－,201603291507
ordinary_income,2013-01-01,2013-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration,-706340000,201603291507
ordinary_income,2015-01-01,2015-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration,－,201603291507
net_income,2010-01-01,2010-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration,－,201603291507
net_income,2011-01-01,2011-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration,－,201603291507
net_income,2012-01-01,2012-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration,－,201603291507
net_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration,-757554000,201603291507
net_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration,－,201603291507
comprehensive_income,2010-01-01,2010-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration,－,201603291507
comprehensive_income,2011-01-01,2011-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration,－,201603291507
comprehensive_income,2012-01-01,2012-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration,－,201603291507
comprehensive_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration,-757554000,201603291507
comprehensive_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration,－,201603291507
net_asset,2010-01-01,2010-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior5YearInstant,－,201603291507
net_asset,2011-01-01,2011-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant,－,201603291507
net_asset,2012-01-01,2012-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant,－,201603291507
net_asset,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant,4559143000,201603291507
net_asset,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant,－,201603291507
total_asset,2010-01-01,2010-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior5YearInstant,－,201603291507
total_asset,2011-01-01,2011-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant,－,201603291507
total_asset,2012-01-01,2012-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant,－,201603291507
total_asset,2013-01-01,2013-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant,5012804000,201603291507
total_asset,2015-01-01,2015-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant,－,201603291507
bps,2010-01-01,2010-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior5YearInstant,－,201603291507
bps,2011-01-01,2011-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant,－,201603291507
bps,2012-01-01,2012-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant,－,201603291507
bps,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant,223.17,201603291507
bps,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant,264.79,201603291507
bps,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant,－,201603291507
eps,2010-01-01,2010-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior5YearDuration,－,201603291507
eps,2011-01-01,2011-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration,－,201603291507
eps,2012-01-01,2012-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration,－,201603291507
eps,2013-01-01,2013-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration,-39.62,201603291507
eps,2015-01-01,2015-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration,－,201603291507
diluted_eps,2010-01-01,2010-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior5YearDuration,－,201603291507
diluted_eps,2011-01-01,2011-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior4YearDuration,－,201603291507
diluted_eps,2012-01-01,2012-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior3YearDuration,－,201603291507
diluted_eps,2013-01-01,2013-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior2YearDuration,－,201603291507
diluted_eps,2015-01-01,2015-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,CurrentYearDuration,－,201603291507
equity_ratio,2010-01-01,2010-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior5YearInstant,－,201603291507
equity_ratio,2011-01-01,2011-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant,－,201603291507
equity_ratio,2012-01-01,2012-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant,－,201603291507
equity_ratio,2013-01-01,2013-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant,0.898,201603291507
equity_ratio,2015-01-01,2015-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant,－,201603291507
roe,2010-01-01,2010-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior5YearDuration,－,201603291507
roe,2011-01-01,2011-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior4YearDuration,－,201603291507
roe,2012-01-01,2012-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior3YearDuration,－,201603291507
roe,2013-01-01,2013-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior2YearDuration,－,201603291507
roe,2014-01-01,2014-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior1YearDuration,－,201603291507
roe,2015-01-01,2015-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,CurrentYearDuration,－,201603291507
number_of_employee,2010-01-01,2010-12-31,jpcrp_cor:NumberOfEmployees,Prior5YearInstant,－,201603291507
number_of_employee,2011-01-01,2011-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant,－,201603291507
number_of_employee,2012-01-01,2012-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant,－,201603291507
number_of_employee,2013-01-01,2013-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant,43,201603291507
number_of_employee,2014-01-01,2014-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant,46,201603291507
number_of_employee,2015-01-01,2015-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant,－,201603291507
number_of_temporary_worker,2010-01-01,2010-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior5YearInstant,－,201603291507
number_of_temporary_worker,2011-01-01,2011-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant,－,201603291507
number_of_temporary_worker,2012-01-01,2012-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant,－,201603291507
number_of_temporary_worker,2013-01-01,2013-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant,21,201603291507
number_of_temporary_worker,2014-01-01,2014-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior1YearInstant,34,201603291507
number_of_temporary_worker,2015-01-01,2015-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant,－,201603291507
number_of_shares,2010-01-01,2010-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior5YearInstant_NonConsolidatedMember,2000,201603291507
number_of_shares,2011-01-01,2011-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,2066000,201603291507
number_of_shares,2012-01-01,2012-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,4330600,201603291507
number_of_shares,2013-01-01,2013-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,10087000,201603291507
number_of_shares,2015-01-01,2015-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,22046200,201603291507
cost_of_sales,2014-01-01,2014-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,89025000,201603291507
cost_of_sales,2015-01-01,2015-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,138057000,201603291507
gross_profit,2014-01-01,2014-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,97412000,201603291507
gross_profit,2015-01-01,2015-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,142056000,201603291507
operating_income,2014-01-01,2014-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-820439000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1269916000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAllianceReportableSegmentsMember,110283000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000LeadAntibodyLicensingReportableSegmentsMember,－,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000LicensingOutPlatformTechnologyReportableSegmentsMember,31772000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember,142056000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,142056000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-1411972000,201603291507
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1269916000,201603291507
net_sales,2016-01-01,2016-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,51832000,201605131553
net_sales,2015-01-01,2015-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,280113000,201605131553
ordinary_income,2016-01-01,2016-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-300643000,201605131553
ordinary_income,2015-01-01,2015-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1253916000,201605131553
net_income,2016-01-01,2016-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-301037000,201605131553
net_income,2015-01-01,2015-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1282714000,201605131553
comprehensive_income,2016-01-01,2016-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-301037000,201605131553
comprehensive_income,2015-01-01,2015-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1282714000,201605131553
net_asset,2016-01-01,2016-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4344648000,201605131553
net_asset,2015-01-01,2015-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,4564241000,201605131553
total_asset,2016-01-01,2016-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4649061000,201605131553
total_asset,2015-01-01,2015-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,4918781000,201605131553
eps,2016-01-01,2016-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-13.62,201605131553
eps,2015-01-01,2015-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-58.29,201605131553
equity_ratio,2016-01-01,2016-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.928,201605131553
equity_ratio,2015-01-01,2015-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.922,201605131553
number_of_shares,2016-01-01,2016-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,22242500,201605131553
number_of_shares,2015-01-01,2015-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,22046200,201605131553
cost_of_sales,2016-01-01,2016-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,31551000,201605131553
gross_profit,2016-01-01,2016-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,20281000,201605131553
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-302385000,201605131553
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,5935000,201605131553
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,14345000,201605131553
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,20281000,201605131553
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-322667000,201605131553
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-302385000,201605131553
net_sales,2016-04-01,2016-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,130474000,201608121507
ordinary_income,2016-04-01,2016-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-580928000,201608121507
net_income,2016-04-01,2016-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-711230000,201608121507
comprehensive_income,2016-04-01,2016-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-711230000,201608121507
net_asset,2016-04-01,2016-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4036865000,201608121507
total_asset,2016-04-01,2016-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4354771000,201608121507
eps,2016-04-01,2016-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-31.99,201608121507
eps,2016-04-01,2016-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-18.34,201608121507
equity_ratio,2016-04-01,2016-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.921,201608121507
number_of_shares,2016-04-01,2016-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,22445500,201608121507
cost_of_sales,2016-04-01,2016-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,76371000,201608121507
gross_profit,2016-04-01,2016-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,54102000,201608121507
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-582694000,201608121507
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,11459000,201608121507
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,42643000,201608121507
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,54102000,201608121507
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-636797000,201608121507
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-582694000,201608121507
net_sales,2015-07-01,2015-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,216532000,201611141502
net_sales,2016-07-01,2016-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,175267000,201611141502
ordinary_income,2015-07-01,2015-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-920486000,201611141502
ordinary_income,2016-07-01,2016-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-827775000,201611141502
net_income,2015-07-01,2015-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-949602000,201611141502
net_income,2016-07-01,2016-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-964511000,201611141502
comprehensive_income,2015-07-01,2015-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-949602000,201611141502
comprehensive_income,2016-07-01,2016-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-964511000,201611141502
net_asset,2016-04-01,2016-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4888767000,201611141502
net_asset,2016-07-01,2016-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3860799000,201611141502
total_asset,2016-04-01,2016-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,5140022000,201611141502
total_asset,2016-07-01,2016-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4093467000,201611141502
eps,2015-07-01,2015-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-43.18,201611141502
eps,2016-07-01,2016-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-43.24,201611141502
eps,2016-04-01,2016-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-12.37,201611141502
eps,2016-07-01,2016-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-11.28,201611141502
diluted_eps,2015-07-01,2015-09-30,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,－,201611141502
equity_ratio,2016-04-01,2016-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.947,201611141502
equity_ratio,2016-07-01,2016-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.930,201611141502
number_of_shares,2016-04-01,2016-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,22046200,201611141502
number_of_shares,2016-07-01,2016-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,22555500,201611141502
cost_of_sales,2015-07-01,2015-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,98014000,201611141502
cost_of_sales,2016-07-01,2016-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,99920000,201611141502
gross_profit,2015-07-01,2015-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,118517000,201611141502
gross_profit,2016-07-01,2016-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,75346000,201611141502
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-936845000,201611141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-827309000,201611141502
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,29455000,201611141502
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,89062000,201611141502
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,118517000,201611141502
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-1055363000,201611141502
operating_income,2015-07-01,2015-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-936845000,201611141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,15682000,201611141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,59664000,201611141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,75346000,201611141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-902656000,201611141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-827309000,201611141502
net_sales,2013-01-01,2013-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration,434962000,201703291606
net_sales,2014-01-01,2014-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration,277759000,201703291606
net_sales,2015-01-01,2015-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration,－,201703291606
ordinary_income,2013-01-01,2013-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration,-706340000,201703291606
ordinary_income,2014-01-01,2014-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration,-883352000,201703291606
ordinary_income,2015-01-01,2015-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration,－,201703291606
net_income,2011-01-01,2011-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration_NonConsolidatedMember,-44417000,201703291606
net_income,2012-01-01,2012-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-426890000,201703291606
net_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-748051000,201703291606
net_income,2014-01-01,2014-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-885498000,201703291606
net_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1491162000,201703291606
comprehensive_income,2011-01-01,2011-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration_NonConsolidatedMember,-44417000,201703291606
comprehensive_income,2012-01-01,2012-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-426890000,201703291606
comprehensive_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-748051000,201703291606
comprehensive_income,2014-01-01,2014-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-885498000,201703291606
comprehensive_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1491162000,201703291606
net_asset,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant,4559143000,201703291606
net_asset,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant,5839466000,201703291606
net_asset,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant,－,201703291606
total_asset,2013-01-01,2013-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant,5012804000,201703291606
total_asset,2014-01-01,2014-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant,6257267000,201703291606
total_asset,2015-01-01,2015-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant,－,201703291606
bps,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant,223.17,201703291606
bps,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant,264.79,201703291606
bps,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant,－,201703291606
eps,2013-01-01,2013-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration,-39.62,201703291606
eps,2014-01-01,2014-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration,-42.36,201703291606
eps,2015-01-01,2015-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration,－,201703291606
equity_ratio,2013-01-01,2013-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant,0.898,201703291606
equity_ratio,2014-01-01,2014-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant,0.929,201703291606
equity_ratio,2015-01-01,2015-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant,－,201703291606
number_of_employee,2013-01-01,2013-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant,43,201703291606
number_of_employee,2014-01-01,2014-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant,46,201703291606
number_of_employee,2015-01-01,2015-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant,－,201703291606
number_of_temporary_worker,2013-01-01,2013-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant,21,201703291606
number_of_temporary_worker,2014-01-01,2014-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant,34,201703291606
number_of_temporary_worker,2015-01-01,2015-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior1YearInstant,－,201703291606
number_of_shares,2011-01-01,2011-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior5YearInstant_NonConsolidatedMember,2066000,201703291606
number_of_shares,2012-01-01,2012-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4330600,201703291606
number_of_shares,2013-01-01,2013-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,10087000,201703291606
number_of_shares,2014-01-01,2014-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,21945800,201703291606
number_of_shares,2016-01-01,2016-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,25455500,201703291606
cost_of_sales,2015-01-01,2015-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,138057000,201703291606
cost_of_sales,2016-01-01,2016-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,137798000,201703291606
gross_profit,2015-01-01,2015-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,142056000,201703291606
gross_profit,2016-01-01,2016-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,114417000,201703291606
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1269916000,201703291606
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1042357000,201703291606
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,33983000,201703291606
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,108072000,201703291606
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,142056000,201703291606
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-1411972000,201703291606
operating_income,2015-01-01,2015-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1269916000,201703291606
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,20184000,201703291606
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,94232000,201703291606
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,114417000,201703291606
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-1156774000,201703291606
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1042357000,201703291606
net_sales,2016-01-01,2016-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,51832000,201705151503
net_sales,2017-01-01,2017-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,55031000,201705151503
net_sales,2016-01-01,2016-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,252215000,201705151503
ordinary_income,2016-01-01,2016-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-300643000,201705151503
ordinary_income,2017-01-01,2017-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-204564000,201705151503
ordinary_income,2016-01-01,2016-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1047157000,201705151503
net_income,2016-01-01,2016-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-301037000,201705151503
net_income,2017-01-01,2017-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-205169000,201705151503
net_income,2016-01-01,2016-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1491162000,201705151503
comprehensive_income,2016-01-01,2016-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-301037000,201705151503
comprehensive_income,2017-01-01,2017-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-205169000,201705151503
comprehensive_income,2016-01-01,2016-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1491162000,201705151503
net_asset,2016-10-01,2016-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4344648000,201705151503
net_asset,2017-01-01,2017-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4557533000,201705151503
net_asset,2016-01-01,2016-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,4565078000,201705151503
total_asset,2016-10-01,2016-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4649061000,201705151503
total_asset,2017-01-01,2017-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4740081000,201705151503
total_asset,2016-01-01,2016-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,4789153000,201705151503
eps,2016-01-01,2016-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-13.62,201705151503
eps,2017-01-01,2017-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-7.93,201705151503
eps,2016-01-01,2016-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-65.91,201705151503
equity_ratio,2016-10-01,2016-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.928,201705151503
equity_ratio,2017-01-01,2017-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.953,201705151503
equity_ratio,2016-01-01,2016-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.945,201705151503
number_of_shares,2016-10-01,2016-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,22242500,201705151503
number_of_shares,2017-01-01,2017-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,25953500,201705151503
number_of_shares,2016-01-01,2016-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,25455500,201705151503
cost_of_sales,2016-01-01,2016-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,31551000,201705151503
cost_of_sales,2017-01-01,2017-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,22826000,201705151503
gross_profit,2016-01-01,2016-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,20281000,201705151503
gross_profit,2017-01-01,2017-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,32204000,201705151503
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-302385000,201705151503
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-203838000,201705151503
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,5935000,201705151503
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,14345000,201705151503
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,20281000,201705151503
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-322667000,201705151503
operating_income,2016-01-01,2016-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-302385000,201705151503
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,2865000,201705151503
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,29338000,201705151503
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,32204000,201705151503
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-236042000,201705151503
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-203838000,201705151503
net_sales,2016-04-01,2016-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,130474000,201708101502
net_sales,2017-04-01,2017-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,102353000,201708101502
ordinary_income,2016-04-01,2016-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-580928000,201708101502
ordinary_income,2017-04-01,2017-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-389614000,201708101502
net_income,2016-04-01,2016-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-711230000,201708101502
net_income,2017-04-01,2017-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-389530000,201708101502
comprehensive_income,2016-04-01,2016-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-711230000,201708101502
comprehensive_income,2017-04-01,2017-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-389530000,201708101502
net_asset,2017-01-01,2017-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4036865000,201708101502
net_asset,2017-04-01,2017-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4710755000,201708101502
total_asset,2017-01-01,2017-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4354771000,201708101502
total_asset,2017-04-01,2017-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4888362000,201708101502
eps,2016-04-01,2016-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-31.99,201708101502
eps,2017-04-01,2017-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-15.02,201708101502
eps,2017-01-01,2017-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-18.34,201708101502
eps,2017-04-01,2017-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-7.09,201708101502
equity_ratio,2017-01-01,2017-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.921,201708101502
equity_ratio,2017-04-01,2017-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.956,201708101502
number_of_shares,2017-01-01,2017-03-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,22445500,201708101502
number_of_shares,2017-04-01,2017-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,26781500,201708101502
cost_of_sales,2016-04-01,2016-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,76371000,201708101502
cost_of_sales,2017-04-01,2017-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,40962000,201708101502
gross_profit,2016-04-01,2016-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,54102000,201708101502
gross_profit,2017-04-01,2017-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,61391000,201708101502
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-582694000,201708101502
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-388949000,201708101502
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,11459000,201708101502
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,42643000,201708101502
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,54102000,201708101502
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-636797000,201708101502
operating_income,2016-04-01,2016-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-582694000,201708101502
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,2865000,201708101502
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,58526000,201708101502
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,61391000,201708101502
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-450341000,201708101502
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-388949000,201708101502
net_sales,2016-07-01,2016-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,175267000,201711141502
net_sales,2017-07-01,2017-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,186410000,201711141502
ordinary_income,2016-07-01,2016-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-827775000,201711141502
ordinary_income,2017-07-01,2017-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-575504000,201711141502
net_income,2016-07-01,2016-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-964511000,201711141502
net_income,2017-07-01,2017-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-574592000,201711141502
comprehensive_income,2016-07-01,2016-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-964511000,201711141502
comprehensive_income,2017-07-01,2017-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-574592000,201711141502
net_asset,2017-04-01,2017-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3860799000,201711141502
net_asset,2017-07-01,2017-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4525577000,201711141502
total_asset,2017-04-01,2017-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4093467000,201711141502
total_asset,2017-07-01,2017-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4710106000,201711141502
eps,2016-07-01,2016-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-43.24,201711141502
eps,2017-07-01,2017-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-21.92,201711141502
eps,2017-04-01,2017-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-11.28,201711141502
eps,2017-07-01,2017-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-6.91,201711141502
equity_ratio,2017-04-01,2017-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.930,201711141502
number_of_shares,2017-04-01,2017-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,22555500,201711141502
cost_of_sales,2016-07-01,2016-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,99920000,201711141502
cost_of_sales,2017-07-01,2017-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,61827000,201711141502
gross_profit,2016-07-01,2016-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,75346000,201711141502
gross_profit,2017-07-01,2017-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,124583000,201711141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-827309000,201711141502
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-574651000,201711141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,15682000,201711141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,59664000,201711141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,75346000,201711141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-902656000,201711141502
operating_income,2016-07-01,2016-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-827309000,201711141502
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,41017000,201711141502
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,83566000,201711141502
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,124583000,201711141502
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-699235000,201711141502
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-574651000,201711141502
net_sales,2013-01-01,2013-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration,434962000,201803261502
net_sales,2014-01-01,2014-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration,277759000,201803261502
net_sales,2015-01-01,2015-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration,－,201803261502
ordinary_income,2013-01-01,2013-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration,-706340000,201803261502
ordinary_income,2014-01-01,2014-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration,-883352000,201803261502
ordinary_income,2015-01-01,2015-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration,－,201803261502
net_income,2012-01-01,2012-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration_NonConsolidatedMember,-426890000,201803261502
net_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-748051000,201803261502
net_income,2014-01-01,2014-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-885498000,201803261502
net_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1282714000,201803261502
net_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-882570000,201803261502
comprehensive_income,2012-01-01,2012-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration_NonConsolidatedMember,-426890000,201803261502
comprehensive_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-748051000,201803261502
comprehensive_income,2014-01-01,2014-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-885498000,201803261502
comprehensive_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1282714000,201803261502
comprehensive_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-882570000,201803261502
net_asset,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant,4559143000,201803261502
net_asset,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant,5839466000,201803261502
net_asset,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant,－,201803261502
total_asset,2013-01-01,2013-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant,5012804000,201803261502
total_asset,2014-01-01,2014-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant,6257267000,201803261502
total_asset,2015-01-01,2015-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant,－,201803261502
bps,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant,223.17,201803261502
bps,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant,264.79,201803261502
bps,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant,－,201803261502
eps,2013-01-01,2013-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration,-39.62,201803261502
eps,2014-01-01,2014-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration,-42.36,201803261502
eps,2015-01-01,2015-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration,－,201803261502
equity_ratio,2013-01-01,2013-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant,0.898,201803261502
equity_ratio,2014-01-01,2014-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant,0.929,201803261502
equity_ratio,2015-01-01,2015-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant,－,201803261502
number_of_employee,2013-01-01,2013-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant,43,201803261502
number_of_employee,2014-01-01,2014-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant,46,201803261502
number_of_employee,2015-01-01,2015-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant,－,201803261502
number_of_temporary_worker,2013-01-01,2013-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant,21,201803261502
number_of_temporary_worker,2014-01-01,2014-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant,34,201803261502
number_of_temporary_worker,2015-01-01,2015-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant,－,201803261502
number_of_shares,2012-01-01,2012-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior5YearInstant_NonConsolidatedMember,4330600,201803261502
number_of_shares,2013-01-01,2013-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,10087000,201803261502
number_of_shares,2014-01-01,2014-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,21945800,201803261502
number_of_shares,2015-01-01,2015-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,22046200,201803261502
number_of_shares,2017-01-01,2017-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,26781500,201803261502
cost_of_sales,2016-01-01,2016-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,137798000,201803261502
cost_of_sales,2017-01-01,2017-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,85481000,201803261502
gross_profit,2016-01-01,2016-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,114417000,201803261502
gross_profit,2017-01-01,2017-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,174414000,201803261502
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1042357000,201803261502
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-887868000,201803261502
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,20184000,201803261502
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,94232000,201803261502
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,114417000,201803261502
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-1156774000,201803261502
operating_income,2016-01-01,2016-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1042357000,201803261502
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,57006000,201803261502
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,117407000,201803261502
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,174414000,201803261502
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-1062282000,201803261502
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-887868000,201803261502
net_sales,2017-01-01,2017-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,55031000,201805151702
net_sales,2018-01-01,2018-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,45354000,201805151702
net_sales,2017-01-01,2017-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,259895000,201805151702
ordinary_income,2017-01-01,2017-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-204564000,201805151702
ordinary_income,2018-01-01,2018-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-300612000,201805151702
ordinary_income,2017-01-01,2017-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-883627000,201805151702
net_income,2017-01-01,2017-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-205169000,201805151702
net_income,2018-01-01,2018-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-301217000,201805151702
net_income,2017-01-01,2017-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-882570000,201805151702
comprehensive_income,2017-01-01,2017-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-205169000,201805151702
comprehensive_income,2018-01-01,2018-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-301217000,201805151702
comprehensive_income,2017-01-01,2017-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-882570000,201805151702
net_asset,2017-10-01,2017-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4557533000,201805151702
net_asset,2018-01-01,2018-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3917042000,201805151702
net_asset,2017-01-01,2017-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,4217574000,201805151702
total_asset,2017-10-01,2017-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4740081000,201805151702
total_asset,2018-01-01,2018-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,4075688000,201805151702
total_asset,2017-01-01,2017-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,4419465000,201805151702
eps,2017-01-01,2017-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-7.93,201805151702
eps,2018-01-01,2018-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-11.25,201805151702
eps,2017-01-01,2017-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-33.48,201805151702
equity_ratio,2017-10-01,2017-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.953,201805151702
equity_ratio,2018-01-01,2018-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.952,201805151702
equity_ratio,2017-01-01,2017-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.946,201805151702
number_of_shares,2017-10-01,2017-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,25953500,201805151702
number_of_shares,2017-01-01,2017-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,26781500,201805151702
cost_of_sales,2017-01-01,2017-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,22826000,201805151702
cost_of_sales,2018-01-01,2018-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,14569000,201805151702
gross_profit,2017-01-01,2017-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,32204000,201805151702
gross_profit,2018-01-01,2018-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,30785000,201805151702
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-203838000,201805151702
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-302748000,201805151702
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-97673000,201805151702
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,29338000,201805151702
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-68334000,201805151702
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-135503000,201805151702
operating_income,2017-01-01,2017-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-203838000,201805151702
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-206786000,201805151702
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,32516000,201805151702
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-174270000,201805151702
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-128478000,201805151702
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-302748000,201805151702
net_sales,2017-04-01,2017-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,102353000,201808141513
net_sales,2018-04-01,2018-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,92669000,201808141513
ordinary_income,2017-04-01,2017-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-389614000,201808141513
ordinary_income,2018-04-01,2018-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-603025000,201808141513
net_income,2017-04-01,2017-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-389530000,201808141513
net_income,2018-04-01,2018-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-603924000,201808141513
comprehensive_income,2017-04-01,2017-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-389530000,201808141513
comprehensive_income,2018-04-01,2018-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-603924000,201808141513
net_asset,2018-01-01,2018-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4710755000,201808141513
net_asset,2018-04-01,2018-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3614708000,201808141513
total_asset,2018-01-01,2018-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4888362000,201808141513
total_asset,2018-04-01,2018-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3795322000,201808141513
eps,2017-04-01,2017-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-15.02,201808141513
eps,2018-04-01,2018-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-22.55,201808141513
eps,2018-01-01,2018-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-7.09,201808141513
eps,2018-04-01,2018-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-11.30,201808141513
equity_ratio,2018-01-01,2018-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.956,201808141513
equity_ratio,2018-04-01,2018-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.943,201808141513
number_of_shares,2018-01-01,2018-03-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,26781500,201808141513
cost_of_sales,2017-04-01,2017-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,40962000,201808141513
cost_of_sales,2018-04-01,2018-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,41100000,201808141513
gross_profit,2017-04-01,2017-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,61391000,201808141513
gross_profit,2018-04-01,2018-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,51569000,201808141513
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-388949000,201808141513
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-607326000,201808141513
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-194942000,201808141513
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,58526000,201808141513
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-136415000,201808141513
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-252533000,201808141513
operating_income,2017-04-01,2017-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-388949000,201808141513
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-436808000,201808141513
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,53090000,201808141513
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-383717000,201808141513
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-223608000,201808141513
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-607326000,201808141513
net_sales,2017-07-01,2017-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,186410000,201811141601
net_sales,2018-07-01,2018-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,142900000,201811141601
ordinary_income,2017-07-01,2017-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-575504000,201811141601
ordinary_income,2018-07-01,2018-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-927702000,201811141601
net_income,2017-07-01,2017-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-574592000,201811141601
net_income,2018-07-01,2018-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-927396000,201811141601
comprehensive_income,2017-07-01,2017-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-574592000,201811141601
comprehensive_income,2018-07-01,2018-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-927396000,201811141601
net_asset,2018-04-01,2018-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4525577000,201811141601
net_asset,2018-07-01,2018-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3283574000,201811141601
total_asset,2018-04-01,2018-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4710106000,201811141601
total_asset,2018-07-01,2018-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3466607000,201811141601
eps,2017-07-01,2017-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-21.92,201811141601
eps,2018-07-01,2018-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-34.63,201811141601
eps,2018-04-01,2018-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-6.91,201811141601
eps,2018-07-01,2018-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-12.08,201811141601
equity_ratio,2018-07-01,2018-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.939,201811141601
cost_of_sales,2017-07-01,2017-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,61827000,201811141601
cost_of_sales,2018-07-01,2018-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,69885000,201811141601
gross_profit,2017-07-01,2017-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,124583000,201811141601
gross_profit,2018-07-01,2018-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,73015000,201811141601
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-574651000,201811141601
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-932267000,201811141601
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-280370000,201811141601
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,83566000,201811141601
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-196804000,201811141601
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-377847000,201811141601
operating_income,2017-07-01,2017-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-574651000,201811141601
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-682823000,201811141601
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,70301000,201811141601
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-612522000,201811141601
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-319745000,201811141601
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-932267000,201811141601
net_sales,2013-01-01,2013-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior5YearDuration,434962000,201903281702
net_sales,2014-01-01,2014-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration,277759000,201903281702
ordinary_income,2013-01-01,2013-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior5YearDuration,-706340000,201903281702
ordinary_income,2014-01-01,2014-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration,-883352000,201903281702
net_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration_NonConsolidatedMember,-748051000,201903281702
net_income,2014-01-01,2014-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-885498000,201903281702
net_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1282714000,201903281702
net_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1491162000,201903281702
net_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1533502000,201903281702
comprehensive_income,2013-01-01,2013-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior5YearDuration_NonConsolidatedMember,-748051000,201903281702
comprehensive_income,2014-01-01,2014-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-885498000,201903281702
comprehensive_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1282714000,201903281702
comprehensive_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1491162000,201903281702
comprehensive_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1533502000,201903281702
net_asset,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior5YearInstant,4559143000,201903281702
net_asset,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant,5839466000,201903281702
total_asset,2013-01-01,2013-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior5YearInstant,5012804000,201903281702
total_asset,2014-01-01,2014-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant,6257267000,201903281702
bps,2013-01-01,2013-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior5YearInstant,223.17,201903281702
bps,2014-01-01,2014-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant,264.79,201903281702
eps,2013-01-01,2013-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior5YearDuration,-39.62,201903281702
eps,2014-01-01,2014-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration,-42.36,201903281702
equity_ratio,2013-01-01,2013-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior5YearInstant,0.898,201903281702
equity_ratio,2014-01-01,2014-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant,0.929,201903281702
number_of_employee,2013-01-01,2013-12-31,jpcrp_cor:NumberOfEmployees,Prior5YearInstant,43,201903281702
number_of_employee,2014-01-01,2014-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant,46,201903281702
number_of_temporary_worker,2013-01-01,2013-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior5YearInstant,21,201903281702
number_of_temporary_worker,2014-01-01,2014-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant,34,201903281702
number_of_shares,2013-01-01,2013-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior5YearInstant_NonConsolidatedMember,10087000,201903281702
number_of_shares,2014-01-01,2014-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,21945800,201903281702
number_of_shares,2015-01-01,2015-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,22046200,201903281702
number_of_shares,2016-01-01,2016-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,25455500,201903281702
cost_of_sales,2017-01-01,2017-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,85481000,201903281702
cost_of_sales,2018-01-01,2018-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,101574000,201903281702
gross_profit,2017-01-01,2017-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,174414000,201903281702
gross_profit,2018-01-01,2018-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,111276000,201903281702
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-887868000,201903281702
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1539121000,201903281702
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-535378000,201903281702
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,117407000,201903281702
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-417970000,201903281702
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-469898000,201903281702
operating_income,2017-01-01,2017-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-887868000,201903281702
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1234364000,201903281702
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,115304000,201903281702
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-1119060000,201903281702
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-420060000,201903281702
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1539121000,201903281702
net_sales,2018-01-01,2018-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,45354000,201905131538
net_sales,2019-01-01,2019-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,63782000,201905131538
net_sales,2018-01-01,2018-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,212851000,201905131538
ordinary_income,2018-01-01,2018-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-300612000,201905131538
ordinary_income,2019-01-01,2019-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-432460000,201905131538
ordinary_income,2018-01-01,2018-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1533952000,201905131538
net_income,2018-01-01,2018-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-301217000,201905131538
net_income,2019-01-01,2019-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-430731000,201905131538
net_income,2018-01-01,2018-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1533502000,201905131538
comprehensive_income,2018-01-01,2018-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-301217000,201905131538
comprehensive_income,2019-01-01,2019-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-430731000,201905131538
comprehensive_income,2018-01-01,2018-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1533502000,201905131538
net_asset,2018-10-01,2018-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3917042000,201905131538
net_asset,2019-01-01,2019-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3048065000,201905131538
net_asset,2018-01-01,2018-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2676719000,201905131538
total_asset,2018-10-01,2018-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,4075688000,201905131538
total_asset,2019-01-01,2019-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3266619000,201905131538
total_asset,2018-01-01,2018-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2831193000,201905131538
eps,2018-01-01,2018-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-11.25,201905131538
eps,2019-01-01,2019-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-15.59,201905131538
eps,2018-01-01,2018-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-57.26,201905131538
equity_ratio,2018-10-01,2018-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.952,201905131538
equity_ratio,2019-01-01,2019-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.925,201905131538
equity_ratio,2018-01-01,2018-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.935,201905131538
number_of_shares,2019-01-01,2019-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,30303500,201905131538
cost_of_sales,2018-01-01,2018-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,14569000,201905131538
cost_of_sales,2019-01-01,2019-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,26547000,201905131538
gross_profit,2018-01-01,2018-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,30785000,201905131538
gross_profit,2019-01-01,2019-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,37234000,201905131538
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-302748000,201905131538
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-426347000,201905131538
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-206786000,201905131538
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,32516000,201905131538
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-174270000,201905131538
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-128478000,201905131538
operating_income,2018-01-01,2018-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-302748000,201905131538
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-362436000,201905131538
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,36637000,201905131538
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-325799000,201905131538
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-100548000,201905131538
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-426347000,201905131538
net_sales,2018-04-01,2018-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,92669000,201908131624
net_sales,2019-04-01,2019-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,140683000,201908131624
ordinary_income,2018-04-01,2018-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-603025000,201908131624
ordinary_income,2019-04-01,2019-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-758731000,201908131624
net_income,2018-04-01,2018-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-603924000,201908131624
net_income,2019-04-01,2019-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-757110000,201908131624
comprehensive_income,2018-04-01,2018-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-603924000,201908131624
comprehensive_income,2019-04-01,2019-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-757110000,201908131624
net_asset,2019-01-01,2019-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3614708000,201908131624
net_asset,2019-04-01,2019-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3174983000,201908131624
total_asset,2019-01-01,2019-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3795322000,201908131624
total_asset,2019-04-01,2019-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3422956000,201908131624
eps,2018-04-01,2018-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-22.55,201908131624
eps,2019-04-01,2019-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-25.49,201908131624
eps,2019-01-01,2019-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-11.30,201908131624
eps,2019-04-01,2019-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-10.28,201908131624
equity_ratio,2019-01-01,2019-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.943,201908131624
equity_ratio,2019-04-01,2019-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.920,201908131624
number_of_shares,2019-04-01,2019-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,32784500,201908131624
cost_of_sales,2018-04-01,2018-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,41100000,201908131624
cost_of_sales,2019-04-01,2019-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,52608000,201908131624
gross_profit,2018-04-01,2018-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,51569000,201908131624
gross_profit,2019-04-01,2019-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,88075000,201908131624
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-607326000,201908131624
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-749708000,201908131624
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-436808000,201908131624
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,53090000,201908131624
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-383717000,201908131624
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-223608000,201908131624
operating_income,2018-04-01,2018-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-607326000,201908131624
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-634982000,201908131624
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,86818000,201908131624
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-548163000,201908131624
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-201545000,201908131624
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-749708000,201908131624
net_sales,2018-07-01,2018-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,142900000,201911121606
net_sales,2019-07-01,2019-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,282690000,201911121606
ordinary_income,2018-07-01,2018-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-927702000,201911121606
ordinary_income,2019-07-01,2019-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1177300000,201911121606
net_income,2018-07-01,2018-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-927396000,201911121606
net_income,2019-07-01,2019-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1170202000,201911121606
comprehensive_income,2018-07-01,2018-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-927396000,201911121606
comprehensive_income,2019-07-01,2019-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1170202000,201911121606
net_asset,2019-04-01,2019-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3283574000,201911121606
net_asset,2019-07-01,2019-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2853260000,201911121606
total_asset,2019-04-01,2019-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3466607000,201911121606
total_asset,2019-07-01,2019-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3048785000,201911121606
eps,2018-07-01,2018-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-34.63,201911121606
eps,2019-07-01,2019-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-37.92,201911121606
eps,2019-04-01,2019-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-12.08,201911121606
eps,2019-07-01,2019-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-12.46,201911121606
equity_ratio,2019-04-01,2019-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.939,201911121606
equity_ratio,2019-07-01,2019-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.929,201911121606
number_of_shares,2019-07-01,2019-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,33283500,201911121606
cost_of_sales,2018-07-01,2018-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,69885000,201911121606
cost_of_sales,2019-07-01,2019-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,110962000,201911121606
gross_profit,2018-07-01,2018-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,73015000,201911121606
gross_profit,2019-07-01,2019-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,171727000,201911121606
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-932267000,201911121606
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-1169015000,201911121606
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-682823000,201911121606
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,70301000,201911121606
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-612522000,201911121606
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-319745000,201911121606
operating_income,2018-07-01,2018-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-932267000,201911121606
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1041557000,201911121606
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,169810000,201911121606
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-871746000,201911121606
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-297269000,201911121606
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-1169015000,201911121606
net_sales,2015-01-01,2015-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,280113000,202003271518
net_sales,2016-01-01,2016-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,252215000,202003271518
net_sales,2017-01-01,2017-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,259895000,202003271518
net_sales,2019-01-01,2019-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,447576000,202003271518
ordinary_income,2015-01-01,2015-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1253916000,202003271518
ordinary_income,2016-01-01,2016-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1047157000,202003271518
ordinary_income,2017-01-01,2017-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-883627000,202003271518
ordinary_income,2019-01-01,2019-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1410314000,202003271518
net_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1282714000,202003271518
net_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1491162000,202003271518
net_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-882570000,202003271518
net_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1403821000,202003271518
comprehensive_income,2015-01-01,2015-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1282714000,202003271518
comprehensive_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1491162000,202003271518
comprehensive_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-882570000,202003271518
comprehensive_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1403821000,202003271518
net_asset,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4564241000,202003271518
net_asset,2016-01-01,2016-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,4565078000,202003271518
net_asset,2017-01-01,2017-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,4217574000,202003271518
net_asset,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,2621508000,202003271518
total_asset,2015-01-01,2015-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4918781000,202003271518
total_asset,2016-01-01,2016-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,4789153000,202003271518
total_asset,2017-01-01,2017-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,4419465000,202003271518
total_asset,2019-01-01,2019-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,2808090000,202003271518
bps,2015-01-01,2015-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,205.78,202003271518
bps,2016-01-01,2016-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,177.87,202003271518
bps,2017-01-01,2017-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,156.15,202003271518
bps,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,98.89,202003271518
bps,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,78.10,202003271518
eps,2015-01-01,2015-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-58.29,202003271518
eps,2016-01-01,2016-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-65.91,202003271518
eps,2017-01-01,2017-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-33.48,202003271518
eps,2019-01-01,2019-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-44.61,202003271518
diluted_eps,2015-01-01,2015-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,－,202003271518
diluted_eps,2016-01-01,2016-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,－,202003271518
diluted_eps,2017-01-01,2017-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,－,202003271518
diluted_eps,2019-01-01,2019-12-31,jpcrp_cor:DilutedEarningsPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,－,202003271518
equity_ratio,2015-01-01,2015-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,0.922,202003271518
equity_ratio,2016-01-01,2016-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,0.945,202003271518
equity_ratio,2017-01-01,2017-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,0.946,202003271518
equity_ratio,2019-01-01,2019-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,0.926,202003271518
roe,2015-01-01,2015-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,－,202003271518
roe,2016-01-01,2016-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,－,202003271518
roe,2017-01-01,2017-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,－,202003271518
roe,2018-01-01,2018-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,－,202003271518
roe,2019-01-01,2019-12-31,jpcrp_cor:RateOfReturnOnEquitySummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,－,202003271518
number_of_employee,2015-01-01,2015-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant_NonConsolidatedMember,60,202003271518
number_of_employee,2016-01-01,2016-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant_NonConsolidatedMember,42,202003271518
number_of_employee,2017-01-01,2017-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant_NonConsolidatedMember,37,202003271518
number_of_employee,2018-01-01,2018-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant_NonConsolidatedMember,37,202003271518
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,38,202003271518
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,38,202003271518
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,29,202003271518
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember,9,202003271518
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,38,202003271518
number_of_temporary_worker,2015-01-01,2015-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant_NonConsolidatedMember,35,202003271518
number_of_temporary_worker,2016-01-01,2016-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant_NonConsolidatedMember,17,202003271518
number_of_temporary_worker,2017-01-01,2017-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant_NonConsolidatedMember,9,202003271518
number_of_temporary_worker,2018-01-01,2018-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior1YearInstant_NonConsolidatedMember,10,202003271518
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,14,202003271518
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,14,202003271518
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,10,202003271518
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember,4,202003271518
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,14,202003271518
number_of_shares,2015-01-01,2015-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,22046200,202003271518
number_of_shares,2016-01-01,2016-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,25455500,202003271518
number_of_shares,2017-01-01,2017-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,26781500,202003271518
number_of_shares,2019-01-01,2019-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,33283500,202003271518
cost_of_sales,2018-01-01,2018-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,101574000,202003271518
cost_of_sales,2019-01-01,2019-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,162929000,202003271518
gross_profit,2018-01-01,2018-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,111276000,202003271518
gross_profit,2019-01-01,2019-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,284647000,202003271518
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1539121000,202003271518
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1401939000,202003271518
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1234364000,202003271518
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,115304000,202003271518
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-1119060000,202003271518
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-420060000,202003271518
operating_income,2018-01-01,2018-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1539121000,202003271518
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1270358000,202003271518
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,255936000,202003271518
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-1014422000,202003271518
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-387517000,202003271518
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1401939000,202003271518
net_sales,2019-01-01,2019-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,63782000,202005151521
net_sales,2020-01-01,2020-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,90755000,202005151521
net_sales,2019-01-01,2019-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,447576000,202005151521
ordinary_income,2019-01-01,2019-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-432460000,202005151521
ordinary_income,2020-01-01,2020-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-424826000,202005151521
ordinary_income,2019-01-01,2019-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1410314000,202005151521
net_income,2019-01-01,2019-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-430731000,202005151521
net_income,2020-01-01,2020-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-425431000,202005151521
net_income,2019-01-01,2019-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1403821000,202005151521
comprehensive_income,2019-01-01,2019-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-430731000,202005151521
comprehensive_income,2020-01-01,2020-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-425431000,202005151521
comprehensive_income,2019-01-01,2019-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1403821000,202005151521
net_asset,2019-10-01,2019-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3048065000,202005151521
net_asset,2020-01-01,2020-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2199378000,202005151521
net_asset,2019-01-01,2019-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2621508000,202005151521
total_asset,2019-10-01,2019-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3266619000,202005151521
total_asset,2020-01-01,2020-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2556082000,202005151521
total_asset,2019-01-01,2019-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2808090000,202005151521
eps,2019-01-01,2019-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-15.59,202005151521
eps,2020-01-01,2020-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-12.78,202005151521
eps,2019-01-01,2019-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-44.61,202005151521
equity_ratio,2019-10-01,2019-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.925,202005151521
equity_ratio,2020-01-01,2020-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.851,202005151521
equity_ratio,2019-01-01,2019-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.926,202005151521
number_of_shares,2019-10-01,2019-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,30303500,202005151521
number_of_shares,2020-01-01,2020-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,33291500,202005151521
number_of_shares,2019-01-01,2019-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,33283500,202005151521
cost_of_sales,2019-01-01,2019-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,26547000,202005151521
cost_of_sales,2020-01-01,2020-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,61153000,202005151521
gross_profit,2019-01-01,2019-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,37234000,202005151521
gross_profit,2020-01-01,2020-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,29601000,202005151521
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-426347000,202005151521
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-426377000,202005151521
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-362436000,202005151521
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,36637000,202005151521
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-325799000,202005151521
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-100548000,202005151521
operating_income,2019-01-01,2019-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-426347000,202005151521
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-341907000,202005151521
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,28928000,202005151521
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-312978000,202005151521
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-113398000,202005151521
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-426377000,202005151521
net_sales,2019-04-01,2019-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,140683000,202008111604
net_sales,2020-04-01,2020-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,173278000,202008111604
ordinary_income,2019-04-01,2019-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-758731000,202008111604
ordinary_income,2020-04-01,2020-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-735874000,202008111604
net_income,2019-04-01,2019-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-757110000,202008111604
net_income,2020-04-01,2020-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-736036000,202008111604
comprehensive_income,2019-04-01,2019-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-757110000,202008111604
comprehensive_income,2020-04-01,2020-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-736036000,202008111604
net_asset,2020-01-01,2020-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3174983000,202008111604
net_asset,2020-04-01,2020-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2585462000,202008111604
total_asset,2020-01-01,2020-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3422956000,202008111604
total_asset,2020-04-01,2020-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3054227000,202008111604
eps,2019-04-01,2019-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-25.49,202008111604
eps,2020-04-01,2020-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-22.01,202008111604
eps,2020-01-01,2020-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-10.28,202008111604
eps,2020-04-01,2020-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-9.25,202008111604
equity_ratio,2020-01-01,2020-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.920,202008111604
equity_ratio,2020-04-01,2020-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.837,202008111604
number_of_shares,2020-01-01,2020-03-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,32784500,202008111604
number_of_shares,2020-04-01,2020-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,35281800,202008111604
cost_of_sales,2019-04-01,2019-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,52608000,202008111604
cost_of_sales,2020-04-01,2020-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,107027000,202008111604
gross_profit,2019-04-01,2019-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,88075000,202008111604
gross_profit,2020-04-01,2020-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,66251000,202008111604
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-749708000,202008111604
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-735779000,202008111604
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-634982000,202008111604
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,86818000,202008111604
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-548163000,202008111604
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-201545000,202008111604
operating_income,2019-04-01,2019-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-749708000,202008111604
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-607377000,202008111604
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,64922000,202008111604
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-542454000,202008111604
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-193325000,202008111604
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-735779000,202008111604
net_sales,2019-07-01,2019-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,282690000,202011101602
net_sales,2020-07-01,2020-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,312284000,202011101602
ordinary_income,2019-07-01,2019-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1177300000,202011101602
ordinary_income,2020-07-01,2020-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1087149000,202011101602
net_income,2019-07-01,2019-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1170202000,202011101602
net_income,2020-07-01,2020-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1087916000,202011101602
comprehensive_income,2019-07-01,2019-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1170202000,202011101602
comprehensive_income,2020-07-01,2020-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1087916000,202011101602
net_asset,2020-04-01,2020-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2853260000,202011101602
net_asset,2020-07-01,2020-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3145700000,202011101602
total_asset,2020-04-01,2020-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3048785000,202011101602
total_asset,2020-07-01,2020-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3565882000,202011101602
eps,2019-07-01,2019-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-37.92,202011101602
eps,2020-07-01,2020-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-31.33,202011101602
eps,2020-04-01,2020-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-12.46,202011101602
eps,2020-07-01,2020-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-9.44,202011101602
equity_ratio,2020-04-01,2020-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.929,202011101602
equity_ratio,2020-07-01,2020-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.874,202011101602
number_of_shares,2020-04-01,2020-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,33283500,202011101602
number_of_shares,2020-07-01,2020-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,38731800,202011101602
cost_of_sales,2019-07-01,2019-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,110962000,202011101602
cost_of_sales,2020-07-01,2020-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,166299000,202011101602
gross_profit,2019-07-01,2019-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,171727000,202011101602
gross_profit,2020-07-01,2020-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,145985000,202011101602
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-1169015000,202011101602
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-1080016000,202011101602
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1041557000,202011101602
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,169810000,202011101602
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-871746000,202011101602
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-297269000,202011101602
operating_income,2019-07-01,2019-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-1169015000,202011101602
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-949048000,202011101602
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,144007000,202011101602
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-805041000,202011101602
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-274974000,202011101602
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-1080016000,202011101602
net_sales,2016-01-01,2016-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,252215000,202103261520
net_sales,2017-01-01,2017-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,259895000,202103261520
net_sales,2018-01-01,2018-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,212851000,202103261520
net_sales,2020-01-01,2020-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,480853000,202103261520
ordinary_income,2016-01-01,2016-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1047157000,202103261520
ordinary_income,2017-01-01,2017-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-883627000,202103261520
ordinary_income,2018-01-01,2018-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1533952000,202103261520
ordinary_income,2020-01-01,2020-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1291606000,202103261520
net_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1491162000,202103261520
net_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-882570000,202103261520
net_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1533502000,202103261520
net_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1293798000,202103261520
comprehensive_income,2016-01-01,2016-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1491162000,202103261520
comprehensive_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-882570000,202103261520
comprehensive_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1533502000,202103261520
comprehensive_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1293798000,202103261520
net_asset,2016-01-01,2016-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4565078000,202103261520
net_asset,2017-01-01,2017-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,4217574000,202103261520
net_asset,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,2676719000,202103261520
net_asset,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,3109968000,202103261520
total_asset,2016-01-01,2016-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4789153000,202103261520
total_asset,2017-01-01,2017-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,4419465000,202103261520
total_asset,2018-01-01,2018-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,2831193000,202103261520
total_asset,2020-01-01,2020-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,3494554000,202103261520
bps,2016-01-01,2016-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,177.87,202103261520
bps,2017-01-01,2017-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,156.15,202103261520
bps,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,98.89,202103261520
bps,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,78.10,202103261520
bps,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,77.99,202103261520
eps,2016-01-01,2016-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-65.91,202103261520
eps,2017-01-01,2017-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-33.48,202103261520
eps,2018-01-01,2018-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-57.26,202103261520
eps,2020-01-01,2020-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-36.06,202103261520
equity_ratio,2016-01-01,2016-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,0.945,202103261520
equity_ratio,2017-01-01,2017-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,0.946,202103261520
equity_ratio,2018-01-01,2018-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,0.935,202103261520
equity_ratio,2020-01-01,2020-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,0.882,202103261520
number_of_employee,2016-01-01,2016-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant_NonConsolidatedMember,42,202103261520
number_of_employee,2017-01-01,2017-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant_NonConsolidatedMember,37,202103261520
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant_NonConsolidatedMember,38,202103261520
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,42,202103261520
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,42,202103261520
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,31,202103261520
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember,11,202103261520
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,42,202103261520
number_of_temporary_worker,2016-01-01,2016-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant_NonConsolidatedMember,17,202103261520
number_of_temporary_worker,2017-01-01,2017-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant_NonConsolidatedMember,9,202103261520
number_of_temporary_worker,2018-01-01,2018-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant_NonConsolidatedMember,10,202103261520
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior1YearInstant_NonConsolidatedMember,14,202103261520
number_of_shares,2016-01-01,2016-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,25455500,202103261520
number_of_shares,2017-01-01,2017-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,26781500,202103261520
number_of_shares,2020-01-01,2020-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,39505200,202103261520
cost_of_sales,2019-01-01,2019-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,162929000,202103261520
cost_of_sales,2020-01-01,2020-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,235582000,202103261520
gross_profit,2019-01-01,2019-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,284647000,202103261520
gross_profit,2020-01-01,2020-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,245270000,202103261520
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1401939000,202103261520
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1283622000,202103261520
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1270358000,202103261520
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,255936000,202103261520
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-1014422000,202103261520
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-387517000,202103261520
operating_income,2019-01-01,2019-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1401939000,202103261520
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1154004000,202103261520
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,242692000,202103261520
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-911312000,202103261520
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-372309000,202103261520
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1283622000,202103261520
net_sales,2020-01-01,2020-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,90755000,202105141703
net_sales,2021-01-01,2021-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,246081000,202105141703
net_sales,2020-01-01,2020-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,480853000,202105141703
ordinary_income,2020-01-01,2020-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-424826000,202105141703
ordinary_income,2021-01-01,2021-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-149640000,202105141703
ordinary_income,2020-01-01,2020-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1291606000,202105141703
net_income,2020-01-01,2020-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-425431000,202105141703
net_income,2021-01-01,2021-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-160704000,202105141703
net_income,2020-01-01,2020-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1293798000,202105141703
comprehensive_income,2020-01-01,2020-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-425431000,202105141703
comprehensive_income,2021-01-01,2021-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-160704000,202105141703
comprehensive_income,2020-01-01,2020-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1293798000,202105141703
net_asset,2020-10-01,2020-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2199378000,202105141703
net_asset,2021-01-01,2021-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3117717000,202105141703
net_asset,2020-01-01,2020-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,3109968000,202105141703
total_asset,2020-10-01,2020-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2556082000,202105141703
total_asset,2021-01-01,2021-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3537405000,202105141703
total_asset,2020-01-01,2020-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,3494554000,202105141703
eps,2020-01-01,2020-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-12.78,202105141703
eps,2021-01-01,2021-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-4.00,202105141703
eps,2020-01-01,2020-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-36.06,202105141703
equity_ratio,2020-10-01,2020-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.851,202105141703
equity_ratio,2021-01-01,2021-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.873,202105141703
equity_ratio,2020-01-01,2020-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.882,202105141703
number_of_shares,2020-10-01,2020-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,33291500,202105141703
number_of_shares,2021-01-01,2021-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,40291500,202105141703
number_of_shares,2020-01-01,2020-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,39505200,202105141703
cost_of_sales,2020-01-01,2020-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,61153000,202105141703
cost_of_sales,2021-01-01,2021-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,63879000,202105141703
gross_profit,2020-01-01,2020-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,29601000,202105141703
gross_profit,2021-01-01,2021-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,182201000,202105141703
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-426377000,202105141703
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-155257000,202105141703
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-341907000,202105141703
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,28928000,202105141703
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-312978000,202105141703
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-113398000,202105141703
operating_income,2020-01-01,2020-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-426377000,202105141703
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-113415000,202105141703
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,79289000,202105141703
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-34126000,202105141703
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-121131000,202105141703
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-155257000,202105141703
net_sales,2020-04-01,2020-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,173278000,202108131607
net_sales,2021-04-01,2021-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,384932000,202108131607
ordinary_income,2020-04-01,2020-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-735874000,202108131607
ordinary_income,2021-04-01,2021-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-409402000,202108131607
net_income,2020-04-01,2020-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-736036000,202108131607
net_income,2021-04-01,2021-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-408737000,202108131607
comprehensive_income,2020-04-01,2020-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-736036000,202108131607
comprehensive_income,2021-04-01,2021-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-408737000,202108131607
net_asset,2021-01-01,2021-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2585462000,202108131607
net_asset,2021-04-01,2021-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2858871000,202108131607
total_asset,2021-01-01,2021-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3054227000,202108131607
total_asset,2021-04-01,2021-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,3328800000,202108131607
eps,2020-04-01,2020-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-22.01,202108131607
eps,2021-04-01,2021-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-10.16,202108131607
eps,2021-01-01,2021-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-9.25,202108131607
eps,2021-04-01,2021-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-6.16,202108131607
equity_ratio,2021-01-01,2021-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.837,202108131607
equity_ratio,2021-04-01,2021-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.853,202108131607
number_of_shares,2021-01-01,2021-03-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,35281800,202108131607
cost_of_sales,2020-04-01,2020-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,107027000,202108131607
cost_of_sales,2021-04-01,2021-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,126089000,202108131607
gross_profit,2020-04-01,2020-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,66251000,202108131607
gross_profit,2021-04-01,2021-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,258843000,202108131607
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-735779000,202108131607
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-415345000,202108131607
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-607377000,202108131607
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,64922000,202108131607
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-542454000,202108131607
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-193325000,202108131607
operating_income,2020-04-01,2020-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-735779000,202108131607
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-356461000,202108131607
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,155931000,202108131607
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-200529000,202108131607
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-214815000,202108131607
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-415345000,202108131607
net_sales,2020-07-01,2020-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,312284000,202111121631
net_sales,2021-07-01,2021-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,541690000,202111121631
ordinary_income,2020-07-01,2020-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1087149000,202111121631
ordinary_income,2021-07-01,2021-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-843016000,202111121631
net_income,2020-07-01,2020-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1087916000,202111121631
net_income,2021-07-01,2021-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-842789000,202111121631
comprehensive_income,2020-07-01,2020-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1087916000,202111121631
comprehensive_income,2021-07-01,2021-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-842789000,202111121631
net_asset,2021-04-01,2021-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3145700000,202111121631
net_asset,2021-07-01,2021-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2428442000,202111121631
total_asset,2021-04-01,2021-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3565882000,202111121631
total_asset,2021-07-01,2021-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2950471000,202111121631
eps,2020-07-01,2020-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-31.33,202111121631
eps,2021-07-01,2021-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-20.94,202111121631
eps,2021-04-01,2021-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-9.44,202111121631
eps,2021-07-01,2021-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-10.77,202111121631
equity_ratio,2021-04-01,2021-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.874,202111121631
equity_ratio,2021-07-01,2021-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.816,202111121631
number_of_shares,2021-04-01,2021-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,38731800,202111121631
number_of_shares,2021-07-01,2021-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,40305500,202111121631
cost_of_sales,2020-07-01,2020-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,166299000,202111121631
cost_of_sales,2021-07-01,2021-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,203898000,202111121631
gross_profit,2020-07-01,2020-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,145985000,202111121631
gross_profit,2021-07-01,2021-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,337792000,202111121631
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-1080016000,202111121631
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-850744000,202111121631
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-949048000,202111121631
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,144007000,202111121631
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-805041000,202111121631
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-274974000,202111121631
operating_income,2020-07-01,2020-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-1080016000,202111121631
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-757382000,202111121631
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,234879000,202111121631
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-522503000,202111121631
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-328241000,202111121631
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-850744000,202111121631
net_sales,2017-01-01,2017-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,259895000,202203251521
net_sales,2018-01-01,2018-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,212851000,202203251521
net_sales,2019-01-01,2019-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,447576000,202203251521
net_sales,2021-01-01,2021-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,712932000,202203251521
ordinary_income,2017-01-01,2017-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-883627000,202203251521
ordinary_income,2018-01-01,2018-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1533952000,202203251521
ordinary_income,2019-01-01,2019-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1410314000,202203251521
ordinary_income,2021-01-01,2021-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1329312000,202203251521
net_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-882570000,202203251521
net_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1533502000,202203251521
net_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1403821000,202203251521
net_income,2021-01-01,2021-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1479895000,202203251521
comprehensive_income,2017-01-01,2017-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-882570000,202203251521
comprehensive_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1533502000,202203251521
comprehensive_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1403821000,202203251521
comprehensive_income,2021-01-01,2021-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1479895000,202203251521
net_asset,2017-01-01,2017-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4217574000,202203251521
net_asset,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,2676719000,202203251521
net_asset,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,2621508000,202203251521
net_asset,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,1893049000,202203251521
total_asset,2017-01-01,2017-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,4419465000,202203251521
total_asset,2018-01-01,2018-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,2831193000,202203251521
total_asset,2019-01-01,2019-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,2808090000,202203251521
total_asset,2021-01-01,2021-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,2339439000,202203251521
bps,2017-01-01,2017-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,156.15,202203251521
bps,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,98.89,202203251521
bps,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,78.10,202203251521
bps,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,77.99,202203251521
bps,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,45.55,202203251521
eps,2017-01-01,2017-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-33.48,202203251521
eps,2018-01-01,2018-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-57.26,202203251521
eps,2019-01-01,2019-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-44.61,202203251521
eps,2021-01-01,2021-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-36.74,202203251521
equity_ratio,2017-01-01,2017-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,0.946,202203251521
equity_ratio,2018-01-01,2018-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,0.935,202203251521
equity_ratio,2019-01-01,2019-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,0.926,202203251521
equity_ratio,2021-01-01,2021-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,0.794,202203251521
number_of_employee,2017-01-01,2017-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant_NonConsolidatedMember,37,202203251521
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant_NonConsolidatedMember,38,202203251521
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant_NonConsolidatedMember,42,202203251521
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,49,202203251521
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,49,202203251521
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,40,202203251521
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,49,202203251521
number_of_temporary_worker,2017-01-01,2017-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant_NonConsolidatedMember,9,202203251521
number_of_temporary_worker,2018-01-01,2018-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant_NonConsolidatedMember,10,202203251521
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant_NonConsolidatedMember,14,202203251521
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,13,202203251521
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,13,202203251521
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember,3,202203251521
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,13,202203251521
number_of_shares,2017-01-01,2017-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,26781500,202203251521
number_of_shares,2019-01-01,2019-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,33283500,202203251521
number_of_shares,2021-01-01,2021-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,40781500,202203251521
cost_of_sales,2020-01-01,2020-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,235582000,202203251521
cost_of_sales,2021-01-01,2021-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,290474000,202203251521
gross_profit,2020-01-01,2020-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,245270000,202203251521
gross_profit,2021-01-01,2021-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,422458000,202203251521
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1283622000,202203251521
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1334319000,202203251521
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1154004000,202203251521
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,242692000,202203251521
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-911312000,202203251521
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-372309000,202203251521
operating_income,2020-01-01,2020-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1283622000,202203251521
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1209270000,202203251521
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,319540000,202203251521
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-889730000,202203251521
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-444589000,202203251521
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1334319000,202203251521
net_sales,2021-01-01,2021-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,246081000,202205131610
net_sales,2022-01-01,2022-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,128571000,202205131610
net_sales,2021-01-01,2021-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,712932000,202205131610
ordinary_income,2021-01-01,2021-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-149640000,202205131610
ordinary_income,2022-01-01,2022-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-491189000,202205131610
ordinary_income,2021-01-01,2021-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1329312000,202205131610
net_income,2021-01-01,2021-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-160704000,202205131610
net_income,2022-01-01,2022-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-492441000,202205131610
net_income,2021-01-01,2021-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1479895000,202205131610
comprehensive_income,2021-01-01,2021-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-160704000,202205131610
comprehensive_income,2022-01-01,2022-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-492441000,202205131610
comprehensive_income,2021-01-01,2021-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1479895000,202205131610
net_asset,2021-10-01,2021-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3117717000,202205131610
net_asset,2022-01-01,2022-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1653544000,202205131610
net_asset,2021-01-01,2021-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,1893049000,202205131610
total_asset,2021-10-01,2021-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3537405000,202205131610
total_asset,2022-01-01,2022-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2126576000,202205131610
total_asset,2021-01-01,2021-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2339439000,202205131610
eps,2021-01-01,2021-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-4.00,202205131610
eps,2022-01-01,2022-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-11.66,202205131610
eps,2021-01-01,2021-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-36.74,202205131610
equity_ratio,2021-10-01,2021-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.873,202205131610
equity_ratio,2022-01-01,2022-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.763,202205131610
equity_ratio,2021-01-01,2021-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.794,202205131610
number_of_shares,2021-10-01,2021-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,40291500,202205131610
number_of_shares,2022-01-01,2022-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,42409900,202205131610
number_of_shares,2021-01-01,2021-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,40781500,202205131610
cost_of_sales,2021-01-01,2021-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,63879000,202205131610
cost_of_sales,2022-01-01,2022-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,57730000,202205131610
gross_profit,2021-01-01,2021-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,182201000,202205131610
gross_profit,2022-01-01,2022-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,70840000,202205131610
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-155257000,202205131610
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-486520000,202205131610
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-113415000,202205131610
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,79289000,202205131610
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-34126000,202205131610
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-121131000,202205131610
operating_income,2021-01-01,2021-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-155257000,202205131610
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-446004000,202205131610
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,70840000,202205131610
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-375163000,202205131610
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-111357000,202205131610
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-486520000,202205131610
net_sales,2021-04-01,2021-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,384932000,202208101508
net_sales,2022-04-01,2022-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,278211000,202208101508
ordinary_income,2021-04-01,2021-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-409402000,202208101508
ordinary_income,2022-04-01,2022-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-768686000,202208101508
net_income,2021-04-01,2021-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-408737000,202208101508
net_income,2022-04-01,2022-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-771005000,202208101508
comprehensive_income,2021-04-01,2021-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-408737000,202208101508
comprehensive_income,2022-04-01,2022-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-771005000,202208101508
net_asset,2022-01-01,2022-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2858871000,202208101508
net_asset,2022-04-01,2022-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1476135000,202208101508
total_asset,2022-01-01,2022-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,3328800000,202208101508
total_asset,2022-04-01,2022-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1920212000,202208101508
eps,2021-04-01,2021-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-10.16,202208101508
eps,2022-04-01,2022-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-18.17,202208101508
eps,2022-01-01,2022-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-6.16,202208101508
eps,2022-04-01,2022-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-6.53,202208101508
equity_ratio,2022-01-01,2022-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.853,202208101508
equity_ratio,2022-04-01,2022-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.753,202208101508
number_of_shares,2022-04-01,2022-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,43057600,202208101508
cost_of_sales,2021-04-01,2021-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,126089000,202208101508
cost_of_sales,2022-04-01,2022-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,127082000,202208101508
gross_profit,2021-04-01,2021-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,258843000,202208101508
gross_profit,2022-04-01,2022-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,151129000,202208101508
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-415345000,202208101508
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-779216000,202208101508
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-356461000,202208101508
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,155931000,202208101508
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-200529000,202208101508
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-214815000,202208101508
operating_income,2021-04-01,2021-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-415345000,202208101508
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-690981000,202208101508
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,151129000,202208101508
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-539851000,202208101508
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-239364000,202208101508
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-779216000,202208101508
net_sales,2021-07-01,2021-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,541690000,202211141610
net_sales,2022-07-01,2022-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,433694000,202211141610
ordinary_income,2021-07-01,2021-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-843016000,202211141610
ordinary_income,2022-07-01,2022-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1029779000,202211141610
net_income,2021-07-01,2021-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-842789000,202211141610
net_income,2022-07-01,2022-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1027559000,202211141610
comprehensive_income,2021-07-01,2021-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-842789000,202211141610
comprehensive_income,2022-07-01,2022-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-1027559000,202211141610
net_asset,2022-04-01,2022-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2428442000,202211141610
net_asset,2022-07-01,2022-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1650378000,202211141610
total_asset,2022-04-01,2022-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2950471000,202211141610
total_asset,2022-07-01,2022-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2081453000,202211141610
eps,2021-07-01,2021-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-20.94,202211141610
eps,2022-07-01,2022-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-23.87,202211141610
eps,2022-04-01,2022-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-10.77,202211141610
eps,2022-07-01,2022-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-5.80,202211141610
equity_ratio,2022-04-01,2022-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.816,202211141610
equity_ratio,2022-07-01,2022-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.784,202211141610
number_of_shares,2022-04-01,2022-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,40305500,202211141610
number_of_shares,2022-07-01,2022-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,45979100,202211141610
cost_of_sales,2021-07-01,2021-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,203898000,202211141610
cost_of_sales,2022-07-01,2022-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,198703000,202211141610
gross_profit,2021-07-01,2021-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,337792000,202211141610
gross_profit,2022-07-01,2022-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,234990000,202211141610
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-850744000,202211141610
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-1039329000,202211141610
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-757382000,202211141610
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,234879000,202211141610
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-522503000,202211141610
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-328241000,202211141610
operating_income,2021-07-01,2021-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-850744000,202211141610
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-916417000,202211141610
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,234990000,202211141610
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-681426000,202211141610
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-357902000,202211141610
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-1039329000,202211141610
net_sales,2018-01-01,2018-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,212851000,202303281616
net_sales,2019-01-01,2019-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,447576000,202303281616
net_sales,2020-01-01,2020-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,480853000,202303281616
net_sales,2022-01-01,2022-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,630815000,202303281616
ordinary_income,2018-01-01,2018-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1533952000,202303281616
ordinary_income,2019-01-01,2019-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1410314000,202303281616
ordinary_income,2020-01-01,2020-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1291606000,202303281616
ordinary_income,2022-01-01,2022-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1243838000,202303281616
net_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1533502000,202303281616
net_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1403821000,202303281616
net_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1293798000,202303281616
net_income,2022-01-01,2022-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1242871000,202303281616
comprehensive_income,2018-01-01,2018-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1533502000,202303281616
comprehensive_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1403821000,202303281616
comprehensive_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1293798000,202303281616
comprehensive_income,2022-01-01,2022-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1242871000,202303281616
net_asset,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,2676719000,202303281616
net_asset,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,2621508000,202303281616
net_asset,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,3109968000,202303281616
net_asset,2022-01-01,2022-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,1790746000,202303281616
total_asset,2018-01-01,2018-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,2831193000,202303281616
total_asset,2019-01-01,2019-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,2808090000,202303281616
total_asset,2020-01-01,2020-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,3494554000,202303281616
total_asset,2022-01-01,2022-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,2215470000,202303281616
bps,2018-01-01,2018-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,98.89,202303281616
bps,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,78.10,202303281616
bps,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,77.99,202303281616
bps,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,45.55,202303281616
bps,2022-01-01,2022-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,36.70,202303281616
eps,2018-01-01,2018-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-57.26,202303281616
eps,2019-01-01,2019-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-44.61,202303281616
eps,2020-01-01,2020-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-36.06,202303281616
eps,2022-01-01,2022-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-28.26,202303281616
equity_ratio,2018-01-01,2018-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,0.935,202303281616
equity_ratio,2019-01-01,2019-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,0.926,202303281616
equity_ratio,2020-01-01,2020-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,0.882,202303281616
equity_ratio,2022-01-01,2022-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,0.802,202303281616
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant_NonConsolidatedMember,38,202303281616
number_of_employee,2020-01-01,2020-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant_NonConsolidatedMember,42,202303281616
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant_NonConsolidatedMember,49,202303281616
number_of_employee,2022-01-01,2022-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,39,202303281616
number_of_employee,2022-01-01,2022-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember,10,202303281616
number_of_temporary_worker,2018-01-01,2018-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant_NonConsolidatedMember,10,202303281616
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant_NonConsolidatedMember,14,202303281616
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior1YearInstant_NonConsolidatedMember,13,202303281616
number_of_shares,2019-01-01,2019-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,33283500,202303281616
number_of_shares,2020-01-01,2020-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,39505200,202303281616
number_of_shares,2022-01-01,2022-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,48423500,202303281616
cost_of_sales,2021-01-01,2021-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,290474000,202303281616
cost_of_sales,2022-01-01,2022-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,281957000,202303281616
gross_profit,2021-01-01,2021-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,422458000,202303281616
gross_profit,2022-01-01,2022-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,348858000,202303281616
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1334319000,202303281616
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1258655000,202303281616
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1209270000,202303281616
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,319540000,202303281616
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-889730000,202303281616
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-444589000,202303281616
operating_income,2021-01-01,2021-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1334319000,202303281616
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1135613000,202303281616
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,348858000,202303281616
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-786755000,202303281616
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-471899000,202303281616
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1258655000,202303281616
net_sales,2022-01-01,2022-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,128571000,202305111617
net_sales,2023-01-01,2023-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,169404000,202305111617
net_sales,2022-01-01,2022-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,630815000,202305111617
ordinary_income,2022-01-01,2022-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-491189000,202305111617
ordinary_income,2023-01-01,2023-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-227433000,202305111617
ordinary_income,2022-01-01,2022-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1243838000,202305111617
net_income,2022-01-01,2022-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-492441000,202305111617
net_income,2023-01-01,2023-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-227683000,202305111617
net_income,2022-01-01,2022-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1242871000,202305111617
comprehensive_income,2022-01-01,2022-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-492441000,202305111617
comprehensive_income,2023-01-01,2023-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-227683000,202305111617
comprehensive_income,2022-01-01,2022-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1242871000,202305111617
net_asset,2022-10-01,2022-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1653544000,202305111617
net_asset,2023-01-01,2023-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1562132000,202305111617
net_asset,2022-01-01,2022-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,1790746000,202305111617
total_asset,2022-10-01,2022-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2126576000,202305111617
total_asset,2023-01-01,2023-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,2085676000,202305111617
total_asset,2022-01-01,2022-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2215470000,202305111617
eps,2022-01-01,2022-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-11.66,202305111617
eps,2023-01-01,2023-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-4.70,202305111617
eps,2022-01-01,2022-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-28.26,202305111617
equity_ratio,2022-10-01,2022-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.763,202305111617
equity_ratio,2023-01-01,2023-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.743,202305111617
equity_ratio,2022-01-01,2022-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.802,202305111617
number_of_shares,2022-10-01,2022-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,42409900,202305111617
number_of_shares,2023-01-01,2023-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,48423500,202305111617
number_of_shares,2022-01-01,2022-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,48423500,202305111617
cost_of_sales,2022-01-01,2022-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,57730000,202305111617
cost_of_sales,2023-01-01,2023-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,73464000,202305111617
gross_profit,2022-01-01,2022-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,70840000,202305111617
gross_profit,2023-01-01,2023-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,95940000,202305111617
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-486520000,202305111617
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-225994000,202305111617
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-446004000,202305111617
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,70840000,202305111617
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-375163000,202305111617
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-111357000,202305111617
operating_income,2022-01-01,2022-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-486520000,202305111617
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-193637000,202305111617
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,95940000,202305111617
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-97697000,202305111617
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-128297000,202305111617
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-225994000,202305111617
net_sales,2022-04-01,2022-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,278211000,202308091621
net_sales,2023-04-01,2023-06-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,358889000,202308091621
ordinary_income,2022-04-01,2022-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-768686000,202308091621
ordinary_income,2023-04-01,2023-06-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-662139000,202308091621
net_income,2022-04-01,2022-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-771005000,202308091621
net_income,2023-04-01,2023-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-663655000,202308091621
comprehensive_income,2022-04-01,2022-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-771005000,202308091621
comprehensive_income,2023-04-01,2023-06-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-663655000,202308091621
net_asset,2023-01-01,2023-03-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1476135000,202308091621
net_asset,2023-04-01,2023-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1144629000,202308091621
total_asset,2023-01-01,2023-03-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1920212000,202308091621
total_asset,2023-04-01,2023-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1685551000,202308091621
eps,2022-04-01,2022-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-18.17,202308091621
eps,2023-04-01,2023-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-13.70,202308091621
eps,2023-01-01,2023-03-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-6.53,202308091621
eps,2023-04-01,2023-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-9.00,202308091621
equity_ratio,2023-01-01,2023-03-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.753,202308091621
equity_ratio,2023-04-01,2023-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.672,202308091621
number_of_shares,2023-01-01,2023-03-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,43057600,202308091621
number_of_shares,2023-04-01,2023-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,48503800,202308091621
cost_of_sales,2022-04-01,2022-06-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,127082000,202308091621
cost_of_sales,2023-04-01,2023-06-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,150211000,202308091621
gross_profit,2022-04-01,2022-06-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,151129000,202308091621
gross_profit,2023-04-01,2023-06-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,208677000,202308091621
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-779216000,202308091621
operating_income,2023-04-01,2023-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-659249000,202308091621
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-690981000,202308091621
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,151129000,202308091621
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-539851000,202308091621
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-239364000,202308091621
operating_income,2022-04-01,2022-06-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-779216000,202308091621
operating_income,2023-04-01,2023-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-601900000,202308091621
operating_income,2023-04-01,2023-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,208677000,202308091621
operating_income,2023-04-01,2023-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-393223000,202308091621
operating_income,2023-04-01,2023-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-266026000,202308091621
operating_income,2023-04-01,2023-06-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-659249000,202308091621
net_sales,2022-07-01,2022-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,433694000,202311141612
net_sales,2023-07-01,2023-09-30,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,524023000,202311141612
ordinary_income,2022-07-01,2022-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1029779000,202311141612
ordinary_income,2023-07-01,2023-09-30,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-916239000,202311141612
net_income,2022-07-01,2022-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1027559000,202311141612
net_income,2023-07-01,2023-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-918465000,202311141612
comprehensive_income,2022-07-01,2022-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-1027559000,202311141612
comprehensive_income,2023-07-01,2023-09-30,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-918465000,202311141612
net_asset,2023-04-01,2023-06-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1650378000,202311141612
net_asset,2023-07-01,2023-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1211022000,202311141612
total_asset,2023-04-01,2023-06-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2081453000,202311141612
total_asset,2023-07-01,2023-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1753201000,202311141612
eps,2022-07-01,2022-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-23.87,202311141612
eps,2023-07-01,2023-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-18.82,202311141612
eps,2023-04-01,2023-06-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1QuarterDuration_NonConsolidatedMember,-5.80,202311141612
eps,2023-07-01,2023-09-30,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentQuarterDuration_NonConsolidatedMember,-5.15,202311141612
equity_ratio,2023-04-01,2023-06-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.784,202311141612
equity_ratio,2023-07-01,2023-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.678,202311141612
number_of_shares,2023-04-01,2023-06-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,45979100,202311141612
number_of_shares,2023-07-01,2023-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,50571400,202311141612
cost_of_sales,2022-07-01,2022-09-30,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,198703000,202311141612
cost_of_sales,2023-07-01,2023-09-30,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,216931000,202311141612
gross_profit,2022-07-01,2022-09-30,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,234990000,202311141612
gross_profit,2023-07-01,2023-09-30,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,307091000,202311141612
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-1039329000,202311141612
operating_income,2023-07-01,2023-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-905313000,202311141612
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-916417000,202311141612
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,234990000,202311141612
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-681426000,202311141612
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-357902000,202311141612
operating_income,2022-07-01,2022-09-30,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-1039329000,202311141612
operating_income,2023-07-01,2023-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-803247000,202311141612
operating_income,2023-07-01,2023-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E26096-000DrugDiscoverySupportReportableSegmentsMember,307091000,202311141612
operating_income,2023-07-01,2023-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-496156000,202311141612
operating_income,2023-07-01,2023-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-409157000,202311141612
operating_income,2023-07-01,2023-09-30,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-905313000,202311141612
net_sales,2019-01-01,2019-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,447576000,202403261644
net_sales,2020-01-01,2020-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,480853000,202403261644
net_sales,2021-01-01,2021-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,712932000,202403261644
net_sales,2023-01-01,2023-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,682464000,202403261644
ordinary_income,2019-01-01,2019-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1410314000,202403261644
ordinary_income,2020-01-01,2020-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1291606000,202403261644
ordinary_income,2021-01-01,2021-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1329312000,202403261644
ordinary_income,2023-01-01,2023-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1217240000,202403261644
net_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1403821000,202403261644
net_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1293798000,202403261644
net_income,2021-01-01,2021-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1479895000,202403261644
net_income,2023-01-01,2023-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1220018000,202403261644
comprehensive_income,2019-01-01,2019-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1403821000,202403261644
comprehensive_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1293798000,202403261644
comprehensive_income,2021-01-01,2021-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1479895000,202403261644
comprehensive_income,2023-01-01,2023-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1220018000,202403261644
net_asset,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,2621508000,202403261644
net_asset,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,3109968000,202403261644
net_asset,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,1893049000,202403261644
net_asset,2023-01-01,2023-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,1157723000,202403261644
total_asset,2019-01-01,2019-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,2808090000,202403261644
total_asset,2020-01-01,2020-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,3494554000,202403261644
total_asset,2021-01-01,2021-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,2339439000,202403261644
total_asset,2023-01-01,2023-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,1751454000,202403261644
bps,2019-01-01,2019-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,78.10,202403261644
bps,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,77.99,202403261644
bps,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,45.55,202403261644
bps,2022-01-01,2022-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,36.70,202403261644
bps,2023-01-01,2023-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,21.66,202403261644
eps,2019-01-01,2019-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-44.61,202403261644
eps,2020-01-01,2020-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-36.06,202403261644
eps,2021-01-01,2021-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-36.74,202403261644
eps,2023-01-01,2023-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-24.62,202403261644
equity_ratio,2019-01-01,2019-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,0.926,202403261644
equity_ratio,2020-01-01,2020-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,0.882,202403261644
equity_ratio,2021-01-01,2021-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,0.794,202403261644
equity_ratio,2023-01-01,2023-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,0.651,202403261644
number_of_employee,2019-01-01,2019-12-31,jpcrp_cor:NumberOfEmployees,Prior4YearInstant_NonConsolidatedMember,38,202403261644
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,Prior2YearInstant_NonConsolidatedMember,49,202403261644
number_of_employee,2023-01-01,2023-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,51,202403261644
number_of_employee,2023-01-01,2023-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,51,202403261644
number_of_employee,2023-01-01,2023-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,51,202403261644
number_of_temporary_worker,2019-01-01,2019-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior4YearInstant_NonConsolidatedMember,14,202403261644
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior2YearInstant_NonConsolidatedMember,13,202403261644
number_of_temporary_worker,2023-01-01,2023-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,17,202403261644
number_of_temporary_worker,2023-01-01,2023-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,17,202403261644
number_of_temporary_worker,2023-01-01,2023-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,13,202403261644
number_of_temporary_worker,2023-01-01,2023-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,17,202403261644
number_of_shares,2019-01-01,2019-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,33283500,202403261644
number_of_shares,2020-01-01,2020-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,39505200,202403261644
number_of_shares,2021-01-01,2021-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,40781500,202403261644
number_of_shares,2023-01-01,2023-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,52640200,202403261644
cost_of_sales,2022-01-01,2022-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,281957000,202403261644
cost_of_sales,2023-01-01,2023-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,283869000,202403261644
gross_profit,2022-01-01,2022-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,348858000,202403261644
gross_profit,2023-01-01,2023-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,398595000,202403261644
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1258655000,202403261644
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1205168000,202403261644
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1135613000,202403261644
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,348858000,202403261644
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-786755000,202403261644
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-471899000,202403261644
operating_income,2022-01-01,2022-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1258655000,202403261644
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1051904000,202403261644
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,398595000,202403261644
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-653309000,202403261644
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-551859000,202403261644
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1205168000,202403261644
net_sales,2023-01-01,2023-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,169404000,202405141612
net_sales,2024-01-01,2024-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,129644000,202405141612
net_sales,2023-01-01,2023-03-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,682464000,202405141612
ordinary_income,2023-01-01,2023-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-227433000,202405141612
ordinary_income,2024-01-01,2024-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-303019000,202405141612
ordinary_income,2023-01-01,2023-03-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1217240000,202405141612
net_income,2023-01-01,2023-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-227683000,202405141612
net_income,2024-01-01,2024-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-304024000,202405141612
net_income,2023-01-01,2023-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1220018000,202405141612
comprehensive_income,2023-01-01,2023-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-227683000,202405141612
comprehensive_income,2024-01-01,2024-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-304024000,202405141612
comprehensive_income,2023-01-01,2023-03-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1220018000,202405141612
net_asset,2023-10-01,2023-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1562132000,202405141612
net_asset,2024-01-01,2024-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1247567000,202405141612
net_asset,2023-01-01,2023-03-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,1157723000,202405141612
total_asset,2023-10-01,2023-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,2085676000,202405141612
total_asset,2024-01-01,2024-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1753934000,202405141612
total_asset,2023-01-01,2023-03-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,1751454000,202405141612
eps,2023-01-01,2023-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-4.70,202405141612
eps,2024-01-01,2024-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-5.60,202405141612
eps,2023-01-01,2023-03-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-24.62,202405141612
equity_ratio,2023-10-01,2023-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.743,202405141612
equity_ratio,2024-01-01,2024-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.704,202405141612
equity_ratio,2023-01-01,2023-03-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.651,202405141612
number_of_shares,2023-10-01,2023-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,48423500,202405141612
number_of_shares,2024-01-01,2024-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,55720600,202405141612
number_of_shares,2023-01-01,2023-03-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,52640200,202405141612
cost_of_sales,2023-01-01,2023-03-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,73464000,202405141612
cost_of_sales,2024-01-01,2024-03-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,72645000,202405141612
gross_profit,2023-01-01,2023-03-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,95940000,202405141612
gross_profit,2024-01-01,2024-03-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,56998000,202405141612
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-225994000,202405141612
operating_income,2024-01-01,2024-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-322155000,202405141612
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-193637000,202405141612
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,95940000,202405141612
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-97697000,202405141612
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-128297000,202405141612
operating_income,2023-01-01,2023-03-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-225994000,202405141612
operating_income,2024-01-01,2024-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-246405000,202405141612
operating_income,2024-01-01,2024-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E26096-000DrugDiscoverySupportReportableSegmentsMember,56998000,202405141612
operating_income,2024-01-01,2024-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-189406000,202405141612
operating_income,2024-01-01,2024-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-132749000,202405141612
operating_income,2024-01-01,2024-03-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-322155000,202405141612
net_sales,2023-01-01,2023-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,358889000,202408131608
net_sales,2024-01-01,2024-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,263728000,202408131608
ordinary_income,2023-01-01,2023-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-662139000,202408131608
ordinary_income,2024-01-01,2024-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-563345000,202408131608
net_income,2023-01-01,2023-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-663655000,202408131608
net_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-563958000,202408131608
comprehensive_income,2023-01-01,2023-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-663655000,202408131608
comprehensive_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-563958000,202408131608
net_asset,2023-10-01,2024-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1144629000,202408131608
net_asset,2024-01-01,2024-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1070531000,202408131608
total_asset,2023-10-01,2024-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1685551000,202408131608
total_asset,2024-01-01,2024-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1557439000,202408131608
eps,2023-01-01,2023-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-13.70,202408131608
eps,2024-01-01,2024-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-10.21,202408131608
equity_ratio,2023-10-01,2024-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.672,202408131608
equity_ratio,2024-01-01,2024-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.680,202408131608
number_of_shares,2023-10-01,2024-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,48503800,202408131608
number_of_shares,2024-01-01,2024-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,56387000,202408131608
cost_of_sales,2023-01-01,2023-12-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,150211000,202408131608
cost_of_sales,2024-01-01,2024-12-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,128970000,202408131608
gross_profit,2023-01-01,2023-12-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,208677000,202408131608
gross_profit,2024-01-01,2024-12-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,134758000,202408131608
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-659249000,202408131608
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-581136000,202408131608
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-601900000,202408131608
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,208677000,202408131608
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-393223000,202408131608
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-266026000,202408131608
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-659249000,202408131608
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-446817000,202408131608
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,134758000,202408131608
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-312059000,202408131608
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-269077000,202408131608
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-581136000,202408131608
net_sales,2020-01-01,2020-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,480853000,202503281605
net_sales,2021-01-01,2021-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,712932000,202503281605
net_sales,2022-01-01,2022-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,630815000,202503281605
net_sales,2024-01-01,2024-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,780809000,202503281605
ordinary_income,2020-01-01,2020-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1291606000,202503281605
ordinary_income,2021-01-01,2021-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1329312000,202503281605
ordinary_income,2022-01-01,2022-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1243838000,202503281605
ordinary_income,2024-01-01,2024-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1019210000,202503281605
net_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1293798000,202503281605
net_income,2021-01-01,2021-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1479895000,202503281605
net_income,2022-01-01,2022-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1242871000,202503281605
net_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1020776000,202503281605
comprehensive_income,2020-01-01,2020-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-1293798000,202503281605
comprehensive_income,2021-01-01,2021-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-1479895000,202503281605
comprehensive_income,2022-01-01,2022-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-1242871000,202503281605
comprehensive_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-1020776000,202503281605
net_asset,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,3109968000,202503281605
net_asset,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,1893049000,202503281605
net_asset,2022-01-01,2022-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,1790746000,202503281605
net_asset,2024-01-01,2024-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,1920303000,202503281605
total_asset,2020-01-01,2020-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,3494554000,202503281605
total_asset,2021-01-01,2021-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,2339439000,202503281605
total_asset,2022-01-01,2022-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,2215470000,202503281605
total_asset,2024-01-01,2024-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,2468857000,202503281605
bps,2020-01-01,2020-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,77.99,202503281605
bps,2021-01-01,2021-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,45.55,202503281605
bps,2022-01-01,2022-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,36.70,202503281605
bps,2023-01-01,2023-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,21.66,202503281605
bps,2024-01-01,2024-12-31,jpcrp_cor:NetAssetsPerShareSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,28.53,202503281605
eps,2020-01-01,2020-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior4YearDuration_NonConsolidatedMember,-36.06,202503281605
eps,2021-01-01,2021-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior3YearDuration_NonConsolidatedMember,-36.74,202503281605
eps,2022-01-01,2022-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior2YearDuration_NonConsolidatedMember,-28.26,202503281605
eps,2024-01-01,2024-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYearDuration_NonConsolidatedMember,-17.54,202503281605
equity_ratio,2020-01-01,2020-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,0.882,202503281605
equity_ratio,2021-01-01,2021-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,0.794,202503281605
equity_ratio,2022-01-01,2022-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,0.802,202503281605
equity_ratio,2024-01-01,2024-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,0.774,202503281605
number_of_employee,2021-01-01,2021-12-31,jpcrp_cor:NumberOfEmployees,Prior3YearInstant_NonConsolidatedMember,49,202503281605
number_of_employee,2023-01-01,2023-12-31,jpcrp_cor:NumberOfEmployees,Prior1YearInstant_NonConsolidatedMember,51,202503281605
number_of_employee,2024-01-01,2024-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,47,202503281605
number_of_employee,2024-01-01,2024-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,47,202503281605
number_of_employee,2024-01-01,2024-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,38,202503281605
number_of_employee,2024-01-01,2024-12-31,jpcrp_cor:NumberOfEmployees,CurrentYearInstant_NonConsolidatedMember,47,202503281605
number_of_temporary_worker,2021-01-01,2021-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior3YearInstant_NonConsolidatedMember,13,202503281605
number_of_temporary_worker,2023-01-01,2023-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,Prior1YearInstant_NonConsolidatedMember,17,202503281605
number_of_temporary_worker,2024-01-01,2024-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,18,202503281605
number_of_temporary_worker,2024-01-01,2024-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,18,202503281605
number_of_temporary_worker,2024-01-01,2024-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember,14,202503281605
number_of_temporary_worker,2024-01-01,2024-12-31,jpcrp_cor:AverageNumberOfTemporaryWorkers,CurrentYearInstant_NonConsolidatedMember,18,202503281605
number_of_shares,2020-01-01,2020-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior4YearInstant_NonConsolidatedMember,39505200,202503281605
number_of_shares,2021-01-01,2021-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior3YearInstant_NonConsolidatedMember,40781500,202503281605
number_of_shares,2022-01-01,2022-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior2YearInstant_NonConsolidatedMember,48423500,202503281605
number_of_shares,2024-01-01,2024-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentYearInstant_NonConsolidatedMember,66969000,202503281605
cost_of_sales,2023-01-01,2023-12-31,jppfs_cor:CostOfSales,Prior1YearDuration_NonConsolidatedMember,283869000,202503281605
cost_of_sales,2024-01-01,2024-12-31,jppfs_cor:CostOfSales,CurrentYearDuration_NonConsolidatedMember,347957000,202503281605
gross_profit,2023-01-01,2023-12-31,jppfs_cor:GrossProfit,Prior1YearDuration_NonConsolidatedMember,398595000,202503281605
gross_profit,2024-01-01,2024-12-31,jppfs_cor:GrossProfit,CurrentYearDuration_NonConsolidatedMember,432851000,202503281605
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1205168000,202503281605
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1030869000,202503281605
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-1051904000,202503281605
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,398595000,202503281605
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-653309000,202503281605
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember,-551859000,202503281605
operating_income,2023-01-01,2023-12-31,jppfs_cor:OperatingIncome,Prior1YearDuration_NonConsolidatedMember,-1205168000,202503281605
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-813784000,202503281605
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E26096-000DrugDiscoverySupportReportableSegmentsMember,309899000,202503281605
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-503885000,202503281605
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember,-526984000,202503281605
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,CurrentYearDuration_NonConsolidatedMember,-1030869000,202503281605
net_sales,2024-01-01,2024-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,263728000,202508121604
net_sales,2025-01-01,2025-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,251796000,202508121604
net_sales,2024-01-01,2024-12-31,jpcrp_cor:NetSalesSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,780809000,202508121604
ordinary_income,2024-01-01,2024-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-563345000,202508121604
ordinary_income,2025-01-01,2025-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-539020000,202508121604
ordinary_income,2024-01-01,2024-12-31,jpcrp_cor:OrdinaryIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1019210000,202508121604
net_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-563958000,202508121604
net_income,2025-01-01,2025-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-540290000,202508121604
net_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1020776000,202508121604
comprehensive_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-563958000,202508121604
comprehensive_income,2025-01-01,2025-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-540290000,202508121604
comprehensive_income,2024-01-01,2024-12-31,jpcrp_cor:NetIncomeLossSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-1020776000,202508121604
net_asset,2024-10-01,2025-09-30,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1070531000,202508121604
net_asset,2025-01-01,2025-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1519330000,202508121604
net_asset,2024-01-01,2024-12-31,jpcrp_cor:NetAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,1920303000,202508121604
total_asset,2024-10-01,2025-09-30,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,1557439000,202508121604
total_asset,2025-01-01,2025-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,1962725000,202508121604
total_asset,2024-01-01,2024-12-31,jpcrp_cor:TotalAssetsSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,2468857000,202508121604
eps,2024-01-01,2024-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YTDDuration_NonConsolidatedMember,-10.21,202508121604
eps,2025-01-01,2025-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,CurrentYTDDuration_NonConsolidatedMember,-7.97,202508121604
eps,2024-01-01,2024-12-31,jpcrp_cor:BasicEarningsLossPerShareSummaryOfBusinessResults,Prior1YearDuration_NonConsolidatedMember,-17.54,202508121604
equity_ratio,2024-10-01,2025-09-30,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,0.680,202508121604
equity_ratio,2025-01-01,2025-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,0.769,202508121604
equity_ratio,2024-01-01,2024-12-31,jpcrp_cor:EquityToAssetRatioSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,0.774,202508121604
number_of_shares,2024-10-01,2025-09-30,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1QuarterInstant_NonConsolidatedMember,56387000,202508121604
number_of_shares,2025-01-01,2025-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,CurrentQuarterInstant_NonConsolidatedMember,68053800,202508121604
number_of_shares,2024-01-01,2024-12-31,jpcrp_cor:TotalNumberOfIssuedSharesSummaryOfBusinessResults,Prior1YearInstant_NonConsolidatedMember,66969000,202508121604
cost_of_sales,2024-01-01,2024-12-31,jppfs_cor:CostOfSales,Prior1YTDDuration_NonConsolidatedMember,128970000,202508121604
cost_of_sales,2025-01-01,2025-12-31,jppfs_cor:CostOfSales,CurrentYTDDuration_NonConsolidatedMember,112930000,202508121604
gross_profit,2024-01-01,2024-12-31,jppfs_cor:GrossProfit,Prior1YTDDuration_NonConsolidatedMember,134758000,202508121604
gross_profit,2025-01-01,2025-12-31,jppfs_cor:GrossProfit,CurrentYTDDuration_NonConsolidatedMember,138866000,202508121604
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-581136000,202508121604
operating_income,2025-01-01,2025-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-536822000,202508121604
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-446817000,202508121604
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,134758000,202508121604
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-312059000,202508121604
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-269077000,202508121604
operating_income,2024-01-01,2024-12-31,jppfs_cor:OperatingIncome,Prior1YTDDuration_NonConsolidatedMember,-581136000,202508121604
operating_income,2025-01-01,2025-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoveryAndDevelopmentReportableSegmentsMember,-395868000,202508121604
operating_income,2025-01-01,2025-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E26096-000DrugDiscoverySupportReportableSegmentsMember,138866000,202508121604
operating_income,2025-01-01,2025-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember,-257002000,202508121604
operating_income,2025-01-01,2025-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember,-279819000,202508121604
operating_income,2025-01-01,2025-12-31,jppfs_cor:OperatingIncome,CurrentYTDDuration_NonConsolidatedMember,-536822000,202508121604
